Associations between serum apelin-12 levels and obesity-related markers in Chinese children

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ba, Hong Jun ^a   Chen, Hong Shan ^a   Su, Zhe ^a   Du, Min Lian ^a   Chen, Qiu Li ^a   Li, Yan Hong ^a   Ma, Hua Mei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; APELIN 12; CHOLESTEROL; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGE; ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPIDS; MALE; OBESITY; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84899944315     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086577     Document Type: Article

References (42)

1. Barlow SE, Expert Committee (2007) Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report. (suppl 4): 164-192.
2. Liu WJ, Lin R, Liu AL, Du L, Chen Q (2010) Prevalence and association between obesity and metabolic syndrome among Chinese elementary school children: a school-based survey. BMC Public Health 10: 780.
3. Rashid MN, Fuentes F, Touchon RC, Wehner PS (2003) Obesity and the risk for cardiovascular disease. Preventive Cardiology6: 42-47. (Pubitemid 36278877)
4. Caprio S (2001) Insulin resistance in childhood obesity. Pediatric Endocrinology and Metabolism (suppl 1): 487-492.
5. Kwiterovich PO Jr (2008) Recognition and management of dyslipidemia in children and adolescents. Journal of Clinical Endocrinology and Metabolism 93: 4200-4209.
6. Weiss R, Kaufman FR (2008) Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care 31 (Suppl 2): 310-316.
7. Arslanian S (2002) Type 2 diabetes in children: clinical aspects and risk factors. Hormone Research (Suppl 1): 19-28.
8. Mattsson N, Rönnemaa T, Juonala M, Viikari JS, Raitakari OT (2008) Childhood predictors of the metabolic syndrome in adulthood. The Cardiovascular Risk in Young Finns Study. Annals of Medicine 40(7): 254-252.
9. Pietrobelli A, Espinoza MC, De Cristofaro P (2008) Childhood obesity: looking into the future. Angiology (Suppl 2): 30-33.
10. Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism 13: 84-89. (Pubitemid 36740452)
11. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307-312. (Pubitemid 32151228)
12. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, et al. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communication 251: 471-476. (Pubitemid 28505047)
13. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, et al. (2000) Characterization of apelin, the ligand for the APJ receptor. Journal of Neurochemistry 74: 34-41. (Pubitemid 30012752)
14. Mesmin C, Fenaille F, Becher F, Tabet JC, Ezan E (2011) Identification and characterization of apelin peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry. Journal of Proteome Research 10: 5222-5231.
15. Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P (2012) Apelin, a promising target for type 2 diabetes treatment? Trends in Endocrinology and Metabolism 23: 234-241.
16. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, et al. (2001) The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regulatory Peptides 99: 87-92. (Pubitemid 32522535)
17. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, et al. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146: 1764-1771. (Pubitemid 40396885)
18. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, et al. (2000) Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. Journal of Biological Chemistry 275: 21061-21067. (Pubitemid 30481796)
19. Szokodi I, Tavi P, Földes G, Voutilainen-Myllylä S, Iives M, et al. (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circulation Research 91: 434-440. (Pubitemid 35034212)
20. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, et al. (2002) The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochemical and Biophysical Research Communications 291: 1208-1212. (Pubitemid 34694318)
21. Reaux-Le Goazigo A, Alvear-Perez R, Zizzari P, Epelbaum J, BLuet-Pajot MT, et al. (2007) Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release. American Journal of Physiology, Endocrinology, and Metabolism 292: E7-15.
22. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, et al. (2006) TNFalpha upregulates apelin expression in human and mouse adipose tissue. The Okodi FASEB Journal 20: 1528-1530.
23. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M, et al. (2007) Growth hormone induces apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes. Regulatory Peptides 139: 84-89. (Pubitemid 46216482)
24. Wei L, Hou X, Tatemoto K (2005) Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regulatory Peptides 132: 27-32. (Pubitemid 41607499)
25. Tasci I, Dogru T, Naharci I, Erdem G, Yilmaz MI, et al. (2007) Plasma apelin is lower in patients with elevated LDL-cholesterol. Experimental and Clinical Endocrinology & Diabetes 115: 428-432. (Pubitemid 47234642)
26. Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S (2008) Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 116: 289-292. (Pubitemid 351798738)
27. Li L, Yang G, Li Q, Tang Y, Yang M, et al. (2006) Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental and Clinical Endocrinology & Diabetes 114: 544-548. (Pubitemid 46087259)
28. Machura E, Szczepanska M, Ziora K, Ziora D, Swietochowska E, et al. Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis. Mediators of Inflammation 2013; doi10.1155/2013/760691.
29. Cekmez F, Cekmez Y, Pirgon O, Canpolat FE, Aydoniz S, et al. (2011) Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome. European Cytokine Network 22: 32-37.
30. Ji CY, Ma J, He ZH, Chen TJ, Song Y, et al. (2010) [Reference norms of waist circumference for Chinese school age children and adolescents]. Chinese Journal of School Health 2010; 31: 257-259. Article in Chinese.
31. Zannolli R, Morgese G (1996) Waist percentiles: a simple test for atherogenic disease? Acta Paediatrics 85: 1368-1369. (Pubitemid 26382389)
32. Tanner JM (1981)Growth and maturation during adolescence. Nutrition Review 39: 43-55.
33. Ten S, Maclaren N (2004) Insulin resistance syndrome in children. Journal of ClinicalEndocrinology & Metabolism 2004; 89: 2526-2539. (Pubitemid 38766328)
34. Heinonen MV, Lääksönen DE, Karhu T, Karhunen L, Laitinen T, et al. (2009) Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutrition Metabolism and Cardiovascular Disease 2009; Mar 9. [Epub ahead of print].
35. Heinonen MV, Purhonen AK, Miettinen P, Pääkkönen M, Pirinen E, et al. (2005) Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regulatory Peptides 130: 7-13. (Pubitemid 40966016)
36. Reinehr T, Woelfle J, Roth CL (2011) Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis. Metabolism Clinical and Experimental 60: 1349-1354.
37. Tapan S, Tacilar E, Abaci A, Sonmez A, Kilic S, et al. (2010) Decreased plasma apelin levels in pubertal obese children. Journal of Pediatric Endocrinology & Metabolism 23: 1039-1046.
38. Böttner A, Katzsch J. Müller G, Kapellen TM, Blüher S, et al. (2004) Gender differences of adiponecin levels develop during the progression of puberty and are related to serum androgen levels. Journal of Clinical Endocrinology & Metabolism 89: 4053-4061. (Pubitemid 39071513)
39. Love-Osborne K, Butler N, Gao D, Zeitler P (2006) Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatric Diabetes 7: 205-210. (Pubitemid 44227660)
40. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metabolic Syndrome and Related Disorders 6: 299-304.
41. Than A, Chen Y, Foh LC, Leow MKS, Lim SC, et al. (2012) Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Molecular and Cellular Endocrinology 362: 227-241.
42. l and AMPK-dependent mechanisms. Energy Balance-Obesity 152: 59-68.